Clinical Trial Update: Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) [Phase 2]

View source ↗

Summary

Phase 2 trial of dupilumab in Allergic bronchopulmonary aspergillosis (LIBERTY ABPA AIRED) has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 2 | Status: COMPLETED | Results posted: 2024-08-21